Vitamin A And D Absorption In Adults With Metabolic Syndrome Versus Healthy Controls: A Pilot Study Utilizing Targeted And Untargeted Lc-Ms Lipidomics

Scope Persons with metabolic syndrome (MetS) absorb less vitamin E than healthy controls. It is hypothesized that absorption of fat-soluble vitamins (FSV) A and D-2 would also decrease with MetS status and that trends would be reflected in lipidomic responses between groups.Methods and Results Following soymilk consumption (501 IU vitamin A, 119 IU vitamin D-2), the triglyceride-rich lipoprotein fractions (TRL) from MetS and healthy subjects (n = 10 age- and gender-matched subjects/group) are assessed using LC-MS/MS. Absorption is calculated using area under the time-concentration curves (AUC) from samples collected at 0, 3, and 6 h post-ingestion. MetS subjects have approximate to 6.4-fold higher median vitamin A AUC (retinyl palmitate) versus healthy controls (P = 0.07). Vitamin D-2 AUC is unaffected by MetS status (P = 0.48). Untargeted LC-MS lipidomics reveals six phospholipids and one cholesterol ester with concentrations correlating (r = 0.53-0.68; P < 0.001) with vitamin A concentration.Conclusions The vitamin A-phospholipid association suggests increased hydrolysis by PLB, PLRP2, and/or PLA(2)IB may be involved in the trend in higher vitamin A bioavailability in MetS subjects. Previously observed differences in circulating levels of these vitamins are likely not due to absorption. Alternate strategies should be investigated to improve FSV status in MetS.